The goal of the Gynecologic Cancers (GC) program is to raise the standard of care and improve clinical outcomes for all women with gynecologic malignancies, with an emphasis on addressing problems relevant to Oklahoma, through conducting transdisciplinary, team-based research.
The Specific Aims are:
- To discover and interrogate molecular mechanisms central to tumor development and progression.
- To develop drugs that translate novel discoveries into early-phase clinical trials
- To design and conduct late-phase randomized clinical trials that advance novel discoveries and improve patient outcomes in the catchment area and the nation.